Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Revenue (2020 - 2022)

Historic Revenue for Immuneering (IMRX) over the last 3 years, with Q4 2022 value amounting to $455.0.

  • Immuneering's Revenue fell 9976.0% to $455.0 in Q4 2022 from the same period last year, while for Sep 2023 it was $455.0, marking a year-over-year decrease of 9991.01%. This contributed to the annual value of $316952.0 for FY2022, which is 8476.16% down from last year.
  • Per Immuneering's latest filing, its Revenue stood at $455.0 for Q4 2022, which was down 9976.0% from $38380.0 recorded in Q3 2022.
  • Immuneering's 5-year Revenue high stood at $748200.0 for Q1 2021, and its period low was $455.0 during Q4 2022.
  • Over the past 3 years, Immuneering's median Revenue value was $480835.0 (recorded in 2020), while the average stood at $384127.1.
  • Per our database at Business Quant, Immuneering's Revenue skyrocketed by 3726.95% in 2021 and then plummeted by 9976.0% in 2022.
  • Quarter analysis of 3 years shows Immuneering's Revenue stood at $665080.0 in 2020, then tumbled by 71.49% to $189591.0 in 2021, then plummeted by 99.76% to $455.0 in 2022.
  • Its Revenue was $455.0 in Q4 2022, compared to $38380.0 in Q3 2022 and $94419.0 in Q2 2022.